Filing Details

Accession Number:
0001209191-13-055995
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-09 19:55:04
Reporting Period:
2013-12-05
Filing Date:
2013-12-09
Accepted Time:
2013-12-09 19:55:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1105941 P David Perry C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-05 12,100 $15.18 249,054 No 4 S Direct
Common Stock Disposition 2013-12-05 2,900 $15.67 246,154 No 4 S Direct
Common Stock Disposition 2013-12-06 5,200 $16.58 240,954 No 4 S Direct
Common Stock Disposition 2013-12-06 9,800 $16.99 231,154 No 4 S Direct
Common Stock Acquisiton 2013-12-09 285,480 $0.60 516,634 No 4 M Direct
Common Stock Disposition 2013-12-09 10,328 $16.72 506,306 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-12-09 285,480 $0.00 285,480 $0.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-06-03 2015-08-25 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopetd by the reporting person on November 19, 2013.
  2. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $14.6100 to $15.5000, inclusive.
  3. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $15.5050 to $15.8650, inclusive.
  4. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $15.9000 to $16.7900, inclusive.
  5. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.8000 to $17.3700, inclusive.
  6. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.69 to $16.84, inclusive.